| abstract |
Provided is a pharmaceutical formulation, comprising an immediate-release section and a delayed-release section, which includes celecoxib a pharmaceutically acceptable salt thereof, a prodrug thereof as an active ingredient. The formulation of the present invention prevents side effects generated by rapid release with high concentrations by dualizing the release of the drugs, and enables a patient to be administered in an easy manner by regulating the blood concentration of the drugs and maximizing the effects of the drugs. |